611
Views
59
CrossRef citations to date
0
Altmetric
Original Articles

PHTHALATES INHIBIT TAMOXIFEN-INDUCED APOPTOSIS IN MCF-7 HUMAN BREAST CANCER CELLS

, &
Pages 2025-2035 | Published online: 12 Aug 2010

REFERENCES

  • Abu-Qare , A. W. and Abou-Donia , M. B. 2001 . Biomarkers of apoptosis: Release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2’-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene . J. Toxicol. Environ. Health B , 4 : 313 – 332 .
  • Ahlborg , U. G. , Lipworth , L. , Titus-Ernstoff , L. , Hsieh , C-C. , Hanberg , A. , Baron , J. , Trichopoulos , D. and Adami , H.-O. 1995 . Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: An assessment of the biological and epidemiological evidence . Crit. Rev. Toxicol. , 25 : 463 – 531 .
  • Andersen , H. R. , Andersson , A.-M. , Arnold , S. F. , Autrup , H. , Barfoed , M. , Beresford , N. A. , Bjerregaard , P. , Christiansen , L. B. , Gissel , B. , Hummel , R. , Jorgensen , E. B. , Korsgaard , B. , Guevel , R. , Leffers , H. , McLachlan , J. , Moller , A. , Nielsen , J. B. , Olea , N. , Oles-Karasko , A. , Pakdel , F. , Pedersen , K. L. , Perez , P. , Skakkeboek , N. E. , Sonnenschein , C. , Soto , A. M. , Sumpter , J. P. , Thorpe , S. M. and Grandjean , P. 1999 . Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals . Environ. Health Perspect. , 107 : 89 – 108 .
  • Choi , S. M. and Lee , B. M. 2004 . An alternative mode of action of endocrine-disrupting chemicals and chemoprevention . J. Toxicol. Environ. Health B. , (In press)
  • Choi , S. M. , Yoo , S. D. and Lee , B. M. 2004 . Toxicological characteristics of endocrine-disrupting chemicals: Developmental toxicity, carcinogenicity, and mutagenicity . J. Toxicol. Environ. Health B , 7 : 1 – 24 .
  • Colborn , T. , Saal , F. S. and Soto , A. M. 1993 . Developmental effects of endocrine-disrupting chemicals in wildlife and humans . Environ. Health Perspect. , 101 : 378 – 384 .
  • DeRosa , C. , Richter , P. , Pohl , H. and Jones , D. E. 1998 . Environmental exposures that affect the endocrine system: Public health implications . J. Toxicol. Environ. Health B , 1 : 3 – 26 .
  • Furr , B. J. A. and Jordan , V. C. 1984 . The pharmacology and clinical uses of tamoxifen . Pharmacol. Ther. , 25 : 127 – 205 .
  • Gavrieli , Y. , Sherman , Y. and Ben-Sasson , S. A. 1992 . Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation . J. Cell Biol. , 119 : 493 – 501 .
  • Gelmann , E. P. 1996 . Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: New tricks for an old dog? . JNCI , 88 : 224 – 226 .
  • Hahm , H. A. and Davidson , N. E. 1998 . Apoptosis in the mammary gland and breast cancer . Endocrine-Related Cancers , 5 : 199 – 211 .
  • Harris , C. A. , Henttu , P. , Parker , M. G. and Sumpter , J. P. 1997 . The estrogenic activity of phthalate esters in vitro . Environ. Health Perspect. , 105 : 802 – 811 .
  • Hashimoto , Y. , Kawaguchi , M. , Miyazaki , K. and Nakamura , M. 2003 . Estrogenic activity of tissue conditioners in vitro . Dent. Mater. , 19 : 341 – 346 .
  • Huang , Y. , Ray , S. , Reed , J. C. , Ibrado , A. M. , Tang , C. , Nawabi , A. and Bhalla , K. 1997 . Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells . Breast Cancer Res. Treat. , 42 : 73 – 81 .
  • Jobling , S. , Reynolds , T. , White , R. , Parker , M. G. and Sumpter , J. P. 1995 . A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic . Environ. Health Perspect. , 103 : 582 – 587 .
  • Jung , M. Y. , Kwon , S. K. and Moon , A. 2001 . Chemopreventive allylthiopyridazine derivatives induce apoptosis in SK-Hep-1 hepatocarcinoma cells through a caspase-3-dependent mechanism . Eur. J. Cancer. , 37 : 2103 – 2109 .
  • Kiess , W. and Gallaher , B. 1998 . Hormonal control of programmed cell death/apoptosis . Eur. J. Endocrinol. , 138 : 482 – 491 .
  • Kobayashi , T. , Ruan , S. , Clodi , K. , Kliche , K. O. , Shiku , H. , Andreeff , M. and Zhang , W. 1998 . Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents . Oncogene , 16 : 1587 – 1591 .
  • Kroemer , G. 1997 . The proto-oncogene Bcl-2 and its role in regulating apoptosis . Nature Med. , 3 : 614 – 620 .
  • Licun , W. and Tannock , I. F. 2003 . Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy . Clin. Cancer Res. , 9 : 4614 – 4618 .
  • Love , R. R. 1989 . Tamoxifen therapy in primary breast cancer: Biology, efficacy, and side effects . J. Clin. Oncol. , 7 : 803 – 815 .
  • Mandlekar , S. , Yu , R. , Tan , T. H. and Kong , A. N. 2000 . Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells . Cancer Res. , 60 : 5995 – 6000 .
  • Marshall , E. 1998 . Tamoxifen. “A big deal,” but a complex hand to play . Science , 280 : 196
  • Nayfield , S. G. 1995 . Tamoxifen's role in chemoprevention of breast cancer: An update . J. Cell Biochem. Suppl. , 22 : 42 – 50 .
  • Oltvai , Z. N. , Milliman , C. L. and Korsmeyer , S. J. 1993 . Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death . Cell , 74 : 609 – 619 .
  • Perry , R. R. , Kang , Y. and Greaves , B. 1995 . Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells . Ann. Surg. Oncol. , 2 : 238 – 245 .
  • Peyrade , F. , Frenay , M. , Etienne , M-C. , Ruch , F. , Guillemare , C. , Francois , E. , Namer , M. , Ferrero , J. M. and Milano , G. 1996 . Age-related differences in tamoxifen disposition . Clin. Pharmacol. Ther. , 59 : 401 – 406 .
  • Picard , K. , Lhuguenot , J. C. , Lavier-Canivenc , M. C. and Chagnon , M. C. 2001 . Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: Identification of the active molecule(s) . Toxicol. Appl. Pharmacol. , 172 : 108 – 118 .
  • Safe , S. H. 2000 . Endocrine disruptors and human health—Is there a problem? An update . Environ. Health Perspect. , 108 : 487 – 493 .
  • Soto , A. M. , Sonnenschein , C. , Chung , K. L. , Fernandez , M. F. , Olea , N. and Serrano , F. O. 1995 . The E‐SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants . Environ. Health Perspect. , 103 : 113 – 122 .
  • Teixeira , C. , Reed , J. C. and Pratt , M. A. 1995 . Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells . Cancer Res. , 55 : 3902 – 3907 .
  • Wang , T. T. and Phang , J. M. 1995 . Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7 . Cancer Res. , 55 : 2487 – 2489 .
  • Yang , E. and Korsmeyer , S. J. 1996 . Molecular thanatopsis: A discourse on the BCL2 family and cell death . Blood , 88 : 386 – 401 .
  • Zhang , G. J. , Kimijima , I. , Onda , M. , Kanno , M. , Sato , H. , Watanabe , T. , Tsuchiya , A. , Abe , R. and Takenoshita , S. 1999 . Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels . Clin. Cancer. Res. , 5 : 2971 – 2977 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.